Brief: Black Diamond Therapeutics Says Dose Expansion Cohorts For Bdtx-1535 Phase 1 Expected To Open In 2023

Black Diamond Therapeutics

17/04/2023 22:34

April 17 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS INC - DOSE EXPANSION COHORTS
FOR
BDTX-1535 PHASE 1 EXPECTED TO OPEN IN 2023 
    * BLACK DIAMOND THERAPEUTICS INC - PHASE 1 BDTX-4933
CLINICAL
STUDY EXPECTED TO INITIATE IN Q2 OF 2023 
    * BLACK DIAMOND THERAPEUTICS PRESENTS TRIAL IN PROGRESS
POSTER FOR
BDTX-1535 AND PRECLINICAL DATA ON BDTX-1535 AND BDTX-4933 AT THE
2023 AMERICAN ASSOCIATION OF CANCER RESEARCH ANNUAL MEETING

Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))